Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07122542
ABSTRACT:
The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
REFERENCES:
patent: 3159547 (1964-12-01), Hollis et al.
patent: 4983608 (1991-01-01), Effland et al.
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 5179204 (1993-01-01), Effland et al.
patent: 5223505 (1993-06-01), Hargreaves
patent: 5420129 (1995-05-01), Breu
patent: 5521184 (1996-05-01), Zimmermann
patent: 5585381 (1996-12-01), Yanaka et al.
patent: 5840893 (1998-11-01), Bukrinsky et al.
patent: 5863924 (1999-01-01), Berger et al.
patent: 5958935 (1999-09-01), Davis et al.
patent: 6004985 (1999-12-01), Kochanny
patent: 6022884 (2000-02-01), Mantlo
patent: 6048866 (2000-04-01), Hutchings et al.
patent: 6080858 (2000-06-01), Schumacher
patent: 6127376 (2000-10-01), Davey et al.
patent: 6197779 (2001-03-01), Andries et al.
patent: 6200977 (2001-03-01), Cushing et al.
patent: 6235746 (2001-05-01), Davis et al.
patent: 6337335 (2002-01-01), Hutchings et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: 6372751 (2002-04-01), Davey et al.
patent: 6432963 (2002-08-01), Hisamichi et al.
patent: 6440986 (2002-08-01), Andries et al.
patent: 6489333 (2002-12-01), Pitts et al.
patent: 6525051 (2003-02-01), Davey et al.
patent: 6528513 (2003-03-01), Cushing et al.
patent: 6579983 (2003-06-01), Batchelor
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 2003/0165873 (2003-09-01), Come et al.
patent: 2004/0043388 (2004-03-01), Come et al.
patent: 2004/0122029 (2004-06-01), Liu et al.
patent: 2005/0209230 (2005-09-01), Singh et al.
patent: 1 056 742 (2000-12-01), None
patent: WO 90/12790 (1990-11-01), None
patent: WO 91/18887 (1991-12-01), None
patent: WO 95/19358 (1995-07-01), None
patent: WO 97/19065 (1998-05-01), None
patent: WO 98/41512 (1998-09-01), None
patent: WO 99/41253 (1999-08-01), None
patent: WO 99/50249 (1999-10-01), None
patent: WO 99/50250 (1999-10-01), None
patent: WO 99/50251 (1999-10-01), None
patent: WO 00/12485 (2000-03-01), None
patent: WO 00/27825 (2000-05-01), None
patent: WO 00/33844 (2000-06-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 00/63182 (2000-10-01), None
patent: WO 00/78731 (2000-12-01), None
patent: WO 01/23389 (2001-05-01), None
patent: WO 01/30782 (2001-05-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/64654 (2001-09-01), None
patent: WO 01/64655 (2001-09-01), None
patent: WO 01/64656 (2001-09-01), None
patent: WO 01/72744 (2001-10-01), None
patent: WO 01/85699 (2001-11-01), None
patent: WO 02/04429 (2002-01-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/50066 (2002-06-01), None
patent: WO 02/059110 (2002-08-01), None
patent: WO 02/059112 (2002-08-01), None
patent: WO 02/062789 (2002-08-01), None
patent: WO 02/064096 (2002-08-01), None
patent: WO 02/066461 (2002-08-01), None
patent: WO 02/066481 (2002-08-01), None
patent: WO 02/102313 (2002-12-01), None
patent: WO 03/000186 (2003-01-01), None
patent: WO 03/002544 (2003-01-01), None
patent: WO 03/016306 (2003-02-01), None
patent: WO 03/018021 (2003-03-01), None
patent: WO 03/018022 (2003-03-01), None
patent: WO 03/026664 (2003-04-01), None
patent: WO 03/026665 (2003-04-01), None
patent: WO 03/026666 (2003-04-01), None
patent: WO 03/030909 (2003-04-01), None
patent: WO 03/040141 (2003-05-01), None
patent: WO 03/045923 (2003-06-01), None
patent: WO 03/048133 (2003-06-01), None
patent: WO 03/062225 (2003-07-01), None
patent: WO 03/063794 (2003-08-01), None
patent: WO 03/066601 (2003-08-01), None
patent: WO 03/074515 (2003-09-01), None
patent: WO 03/078404 (2003-09-01), None
patent: WO 03/094920 (2003-11-01), None
patent: WO 04/014382 (2004-02-01), None
patent: WO 2004/014382 (2004-02-01), None
patent: WO 2004/039359 (2004-05-01), None
patent: WO 200/046118 (2004-06-01), None
patent: WO 2004/048343 (2004-06-01), None
patent: WO 2004/050068 (2004-06-01), None
patent: WO 2004/056786 (2004-07-01), None
patent: WO 2004/069812 (2004-08-01), None
patent: WO 2004/074244 (2004-09-01), None
patent: WO 2004/074261 (2004-09-01), None
patent: WO 2004/074262 (2004-09-01), None
patent: WO 2004/080980 (2004-09-01), None
Manesiotis et al., “Improved Imide Receptors by Imprinting Using Pyrimidine-Based Fluorescent Reporter Monomers,”J. Org. Chem., 2005, 70:2729-2738.
Cores: An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes, Hare, Brain J., Journal of Chemistry (2004)47(19), 4731-4740.
Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC 125-R165335 (Etravirine) and related non-nucleoside reverse transcriptase inhibitors that are hightly potent and effective against wild-type and drug-resistant HIV-1variants. Das, Kalyan; Journal of Medicinal Chemistry (2004), 47(10), 2550-2560.
Identification of Compounds with Nanomolr binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual Screening. Lyne, Pauld D.; Journal of Medicinal Chemistry (2004) 47(8), 1962-1968.
Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimization of substituted 2,4-bis anilino pyrimidines. Bioorganic & Medicinal Chemistry Letters (2203), 13(18), 2961-2966.
Argade Ankush
Bhamidipati Somasekhar
Carroll David
Clough Jeffrey
Keim Holger
Dechert LLP
Johnsen Jason H.
Rigel Pharmaceuticals Inc.
Wilson James O.
LandOfFree
Methods of treating or preventing autoimmune diseases with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating or preventing autoimmune diseases with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating or preventing autoimmune diseases with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3666267